Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anti-Infective Drugs refer to various drugs used to treat infections caused by pathogens.
For decades, anti-infective drugs have been one of the main businesses of many pharmaceutical companies. Over the past two decades, infection rates have increased significantly, especially in low- and middle-income countries.
The main driver of market growth is the increase in several infectious diseases in developed and emerging markets, which requires more attention from pharmaceutical and biotechnology companies. In addition, the number of multidrug-resistant organisms has increased significantly around the world, further increasing the importance of anti-infective drug innovation and driving the market.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Anti-Infective Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Anti-Infective Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Anti-Infective Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novabay Pharmaceuticals
MerLion Pharma
Nanosphere
Roche Pharma AG
Daiichi Sankyo
Sanofi-Aventis
Pfizer
Bristol-Myers Squibb
GlaxoSmithKline
Johnson
Wyeth
Optimer Pharmaceuticals
NanoViricides
Theravance
Obetech
Gilead Sciences
Abbott
Novartis AG
Merck
Basilea Pharmaceutica AG
By Type:
OTC
Rx Drugs
By End-User:
Hospital
Drugs Store
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-Infective Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Anti-Infective Drugs Market Size and Growth Rate of OTC from 2016 to 2027
-
1.3.2 USA Anti-Infective Drugs Market Size and Growth Rate of Rx Drugs from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Anti-Infective Drugs Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 USA Anti-Infective Drugs Market Size and Growth Rate of Drugs Store from 2016 to 2027
-
1.4.3 USA Anti-Infective Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Anti-Infective Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Anti-Infective Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Anti-Infective Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Anti-Infective Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Anti-Infective Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Anti-Infective Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of OTC
-
3.4.2 Market Size and Growth Rate of Rx Drugs
4 Segmentation of Anti-Infective Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Anti-Infective Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Anti-Infective Drugs in Hospital
-
4.4.2 Market Size and Growth Rate of Anti-Infective Drugs in Drugs Store
-
4.4.3 Market Size and Growth Rate of Anti-Infective Drugs in Other
5 Market Analysis by Regions
-
5.1 USA Anti-Infective Drugs Production Analysis by Regions
-
5.2 USA Anti-Infective Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Anti-Infective Drugs Landscape Analysis
-
6.1 West USA Anti-Infective Drugs Landscape Analysis by Major Types
-
6.2 West USA Anti-Infective Drugs Landscape Analysis by Major End-Users
7 South USA Anti-Infective Drugs Landscape Analysis
-
7.1 South USA Anti-Infective Drugs Landscape Analysis by Major Types
-
7.2 South USA Anti-Infective Drugs Landscape Analysis by Major End-Users
8 Middle West USA Anti-Infective Drugs Landscape Analysis
-
8.1 Middle West USA Anti-Infective Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Anti-Infective Drugs Landscape Analysis by Major End-Users
9 Northeast USA Anti-Infective Drugs Landscape Analysis
-
9.1 Northeast USA Anti-Infective Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Anti-Infective Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Novabay Pharmaceuticals
-
10.1.1 Novabay Pharmaceuticals Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 MerLion Pharma
-
10.2.1 MerLion Pharma Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Nanosphere
-
10.3.1 Nanosphere Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Roche Pharma AG
-
10.4.1 Roche Pharma AG Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Daiichi Sankyo
-
10.5.1 Daiichi Sankyo Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Sanofi-Aventis
-
10.6.1 Sanofi-Aventis Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Pfizer
-
10.7.1 Pfizer Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Bristol-Myers Squibb
-
10.8.1 Bristol-Myers Squibb Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 GlaxoSmithKline
-
10.9.1 GlaxoSmithKline Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Johnson
-
10.10.1 Johnson Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Wyeth
-
10.11.1 Wyeth Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Optimer Pharmaceuticals
-
10.12.1 Optimer Pharmaceuticals Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 NanoViricides
-
10.13.1 NanoViricides Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Theravance
-
10.14.1 Theravance Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 Obetech
-
10.15.1 Obetech Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
-
10.16 Gilead Sciences
-
10.16.1 Gilead Sciences Company Profile and Recent Development
-
10.16.2 Market Performance
-
10.16.3 Product and Service Introduction
-
10.17 Abbott
-
10.17.1 Abbott Company Profile and Recent Development
-
10.17.2 Market Performance
-
10.17.3 Product and Service Introduction
-
10.18 Novartis AG
-
10.18.1 Novartis AG Company Profile and Recent Development
-
10.18.2 Market Performance
-
10.18.3 Product and Service Introduction
-
10.19 Merck
-
10.19.1 Merck Company Profile and Recent Development
-
10.19.2 Market Performance
-
10.19.3 Product and Service Introduction
-
10.20 Basilea Pharmaceutica AG
-
10.20.1 Basilea Pharmaceutica AG Company Profile and Recent Development
-
10.20.2 Market Performance
-
10.20.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Anti-Infective Drugs Market Size and Growth Rate of OTC from 2016 to 2027
-
Figure USA Anti-Infective Drugs Market Size and Growth Rate of Rx Drugs from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Anti-Infective Drugs Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Anti-Infective Drugs Market Size and Growth Rate of Drugs Store from 2016 to 2027
-
Figure USA Anti-Infective Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Anti-Infective Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Anti-Infective Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Anti-Infective Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Anti-Infective Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Anti-Infective Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Anti-Infective Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Anti-Infective Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Anti-Infective Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of OTC
-
Figure Market Size and Growth Rate of Rx Drugs
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Anti-Infective Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Anti-Infective Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Drugs Store
-
Figure Market Size and Growth Rate of Other
-
Table USA Anti-Infective Drugs Production by Regions
-
Table USA Anti-Infective Drugs Production Share by Regions
-
Figure USA Anti-Infective Drugs Production Share by Regions in 2016
-
Figure USA Anti-Infective Drugs Production Share by Regions in 2021
-
Figure USA Anti-Infective Drugs Production Share by Regions in 2027
-
Table USA Anti-Infective Drugs Consumption by Regions
-
Table USA Anti-Infective Drugs Consumption Share by Regions
-
Figure USA Anti-Infective Drugs Consumption Share by Regions in 2016
-
Figure USA Anti-Infective Drugs Consumption Share by Regions in 2021
-
Figure USA Anti-Infective Drugs Consumption Share by Regions in 2027
-
Table West USA Anti-Infective Drugs Consumption by Types from 2016 to 2027
-
Table West USA Anti-Infective Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Anti-Infective Drugs Consumption Share by Types in 2016
-
Figure West USA Anti-Infective Drugs Consumption Share by Types in 2021
-
Figure West USA Anti-Infective Drugs Consumption Share by Types in 2027
-
Table West USA Anti-Infective Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Anti-Infective Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Anti-Infective Drugs Consumption Share by End-Users in 2016
-
Figure West USA Anti-Infective Drugs Consumption Share by End-Users in 2021
-
Figure West USA Anti-Infective Drugs Consumption Share by End-Users in 2027
-
Table South USA Anti-Infective Drugs Consumption by Types from 2016 to 2027
-
Table South USA Anti-Infective Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Anti-Infective Drugs Consumption Share by Types in 2016
-
Figure South USA Anti-Infective Drugs Consumption Share by Types in 2021
-
Figure South USA Anti-Infective Drugs Consumption Share by Types in 2027
-
Table South USA Anti-Infective Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Anti-Infective Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Anti-Infective Drugs Consumption Share by End-Users in 2016
-
Figure South USA Anti-Infective Drugs Consumption Share by End-Users in 2021
-
Figure South USA Anti-Infective Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Anti-Infective Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Anti-Infective Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Anti-Infective Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Anti-Infective Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Anti-Infective Drugs Consumption Share by Types in 2027
-
Table Middle West USA Anti-Infective Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Anti-Infective Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Anti-Infective Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Anti-Infective Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Anti-Infective Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Anti-Infective Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Anti-Infective Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Anti-Infective Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Anti-Infective Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Anti-Infective Drugs Consumption Share by Types in 2027
-
Table Northeast USA Anti-Infective Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Anti-Infective Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Anti-Infective Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Anti-Infective Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Anti-Infective Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Novabay Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novabay Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Novabay Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Novabay Pharmaceuticals
-
Table Product and Service Introduction of Novabay Pharmaceuticals
-
Table Company Profile and Development Status of MerLion Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MerLion Pharma
-
Figure Sales and Growth Rate Analysis of MerLion Pharma
-
Figure Revenue and Market Share Analysis of MerLion Pharma
-
Table Product and Service Introduction of MerLion Pharma
-
Table Company Profile and Development Status of Nanosphere
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nanosphere
-
Figure Sales and Growth Rate Analysis of Nanosphere
-
Figure Revenue and Market Share Analysis of Nanosphere
-
Table Product and Service Introduction of Nanosphere
-
Table Company Profile and Development Status of Roche Pharma AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Pharma AG
-
Figure Sales and Growth Rate Analysis of Roche Pharma AG
-
Figure Revenue and Market Share Analysis of Roche Pharma AG
-
Table Product and Service Introduction of Roche Pharma AG
-
Table Company Profile and Development Status of Daiichi Sankyo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo
-
Figure Sales and Growth Rate Analysis of Daiichi Sankyo
-
Figure Revenue and Market Share Analysis of Daiichi Sankyo
-
Table Product and Service Introduction of Daiichi Sankyo
-
Table Company Profile and Development Status of Sanofi-Aventis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis
-
Figure Sales and Growth Rate Analysis of Sanofi-Aventis
-
Figure Revenue and Market Share Analysis of Sanofi-Aventis
-
Table Product and Service Introduction of Sanofi-Aventis
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson
-
Figure Sales and Growth Rate Analysis of Johnson
-
Figure Revenue and Market Share Analysis of Johnson
-
Table Product and Service Introduction of Johnson
-
Table Company Profile and Development Status of Wyeth
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wyeth
-
Figure Sales and Growth Rate Analysis of Wyeth
-
Figure Revenue and Market Share Analysis of Wyeth
-
Table Product and Service Introduction of Wyeth
-
Table Company Profile and Development Status of Optimer Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Optimer Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Optimer Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Optimer Pharmaceuticals
-
Table Product and Service Introduction of Optimer Pharmaceuticals
-
Table Company Profile and Development Status of NanoViricides
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NanoViricides
-
Figure Sales and Growth Rate Analysis of NanoViricides
-
Figure Revenue and Market Share Analysis of NanoViricides
-
Table Product and Service Introduction of NanoViricides
-
Table Company Profile and Development Status of Theravance
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Theravance
-
Figure Sales and Growth Rate Analysis of Theravance
-
Figure Revenue and Market Share Analysis of Theravance
-
Table Product and Service Introduction of Theravance
-
Table Company Profile and Development Status of Obetech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Obetech
-
Figure Sales and Growth Rate Analysis of Obetech
-
Figure Revenue and Market Share Analysis of Obetech
-
Table Product and Service Introduction of Obetech
-
Table Company Profile and Development Status of Gilead Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences
-
Figure Sales and Growth Rate Analysis of Gilead Sciences
-
Figure Revenue and Market Share Analysis of Gilead Sciences
-
Table Product and Service Introduction of Gilead Sciences
-
Table Company Profile and Development Status of Abbott
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
-
Figure Sales and Growth Rate Analysis of Abbott
-
Figure Revenue and Market Share Analysis of Abbott
-
Table Product and Service Introduction of Abbott
-
Table Company Profile and Development Status of Novartis AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Basilea Pharmaceutica AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Basilea Pharmaceutica AG
-
Figure Sales and Growth Rate Analysis of Basilea Pharmaceutica AG
-
Figure Revenue and Market Share Analysis of Basilea Pharmaceutica AG
-
Table Product and Service Introduction of Basilea Pharmaceutica AG
-
